ABSTRACT

Fact Sheet for Healthcare Providers: Bioeksen R&D Technologies Ltd., Bio-Speedy Direct RT-qPCR SARS-CoV-2   [open pdf - 145KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Bio-Speedy Direct RT-qPCR SARS-CoV-2 [real-time quantitative polymerase chain reaction severe acute respiratory syndrome coronavirus 2]. The Bio-Speedy Direct RT-qPCR SARS-CoV-2 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider."

Publisher:
Date:
2020-09-02
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations